NCT02600455已完成不适用
Outline of Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL
Bristol-Myers Squibb1 个研究点 分布在 1 个国家目标入组 505 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 505
- 试验地点
- 1
- 主要终点
- Safety measured by number of Adverse events and laboratory abnormalities associated with adverse events
研究概览
简要总结
The purpose of this study to collect information on the safety, especially localized injection site reactions, and efficacy of ORENCIA Subcutaneous Injection 125mg Syringe 1mL in patients with rheumatoid arthritis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are beginning to receive the treatment with ORENCIA Subcutaneous Injection 125mg Syringe 1mL under the approved indications, dosage, and administration
排除标准
- 未提供
研究组 & 干预措施
Patients who are treated with ORENCIA
Patients who are treated with ORENCIA according to the approved indications, and dosage and administration
干预措施: Orencia (Drug)
结局指标
主要结局
Safety measured by number of Adverse events and laboratory abnormalities associated with adverse events
时间窗: 24 weeks
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Prospective Study Looking at the Use of Rebif® in Subjects With Clinically Isolated SyndromeClinically Isolated SyndromeNCT00287079Merck KGaA, Darmstadt, Germany35
终止
3 期
Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)ThrombosisCancerNCT00311896Clinica Universidad de Navarra, Universidad de Navarra402
已完成
1 期
Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy SubjectsCicatrixRe-epithelialisationNCT00984854Renovo70
已完成
不适用
A Study on the Safety and Effectiveness of Subcutaneous Silicone Penile Implant SurgeryPenile ImplantNCT04985123International Medical Devices, Inc.40
撤回
不适用
Safety and Efficacy of a Sub-epitheilal Transform™ Corneal Allograft (TCA) for Presbyopia CorrectionRefractive ErrorsPresbyopiaNCT03675438Allotex, Inc.